ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization
Anergis is a clinical-stage biopharmaceutical company based in Switzerland. Anergis discovers and develops proprietary synthetic allergy vaccines with the aim to provide allergy patients and doctors ...load more
ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization's Basic Information
Industry
Headquarters
Switzerland
Website
Headcount
2 - 10 ( View All )
Specialties
The Future of Allergy Treatment: Ultra-Fast DesensitizationPharmaceutical quality productsCOP allergy vaccines technologyRe-engineered SIT with synthetic long peptides• Complete allergen sequence covering all T cell epitopes
ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization's Competitors
Vallait SA
View all employeesSciGen Ltd., Singapore
View all employeeslaimat soluciones científico técnias
View all employeesEmployee Insights
ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization's Top Employees
Vincent Charlon
CEO
Phone Email
Christophe Reymond
CSO
Phone Email
Vanya Beltrami
VP, Head of Manufacturing
Phone Email
Frequently Asked Questions Regarding ANERGIS The Future of Allergy Treatment: Ultra-Fast Desensitization
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts